DHER:XETRDelivery Hero SE Analysis
Data as of 2026-06-13 - not real-time
€37.64
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Delivery Hero is trading at €37.64, comfortably above its 20‑day, 50‑day and 200‑day SMAs (≈€36.7, €26.8 and €23.0) indicating a bullish price backdrop, but the RSI sits at 67 points and the MACD histogram is negative, signalling short‑term overbought pressure and a bearish momentum shift.
Fundamentally the company posted 10 % revenue growth and a 30 % jump in adjusted EBITDA for FY2025, with free cash flow up 15 %, yet its forward P/E of 44×, debt‑to‑equity of ~258 % and a DCF fair‑value of roughly €15.5 place the stock in clear overvaluation territory (≈‑12 % downside to intrinsic value). The recent surge in Uber’s stake to ~37 % adds strategic upside but also takeover uncertainty, while the high 30‑day volatility (~69 %) and decreasing volume underline heightened market risk.
Fundamentally the company posted 10 % revenue growth and a 30 % jump in adjusted EBITDA for FY2025, with free cash flow up 15 %, yet its forward P/E of 44×, debt‑to‑equity of ~258 % and a DCF fair‑value of roughly €15.5 place the stock in clear overvaluation territory (≈‑12 % downside to intrinsic value). The recent surge in Uber’s stake to ~37 % adds strategic upside but also takeover uncertainty, while the high 30‑day volatility (~69 %) and decreasing volume underline heightened market risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI approaching overbought levels
- Bearish MACD crossover
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong top‑line and EBITDA growth
- Elevated debt load and valuation premium
- Potential strategic impact of Uber’s increasing stake
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Projected 8‑10 % GMV growth through 2026
- Strategic partnership/possible integration with Uber
- Market leadership across ~70 countries despite short‑term pricing pressure
Key Metrics & Analysis
Financial Health
Revenue Growth10.10%
Profit Margin-5.57%
P/E Ratio44.1
ROE-30.99%
ROA0.52%
Debt/Equity257.86
P/B Ratio6.8
Op. Cash Flow€79.5M
Free Cash Flow€355.6M
Technical Analysis
TrendBullish
RSI67.4
Support€28.04
Resistance€39.83
MA 20€36.70
MA 50€26.80
MA 200€22.97
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value€15.47
Target Price€33.09
Upside/Downside-12.08%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.90
Volatility69.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.